• Optimizing Epigenetics Research: Applied Workflows with (-)-

  2026-05-16

  (-)-JQ1, the gold-standard JQ1 stereoisomer, empowers rigorous BET bromodomain inhibitor studies by serving as an inactive negative control. This article translates cutting-edge findings on BET inhibition in HPV-16 HNSCC into actionable protocols, advanced troubleshooting, and data-integrity strategies for cancer biology research.

• Bufalin: Cardiotonic Steroid Mechanisms in Cancer Research

  2026-05-15

  Bufalin is a cardiotonic steroid with validated apoptotic and protein degradation activity in cancer models. It directly targets STK33 in triple-negative breast cancer and modulates key signaling pathways. This article summarizes mechanistic, benchmark, and workflow evidence for Bufalin in oncology research.

• Next-Gen Protein Preservation: Translational Insights for Pl

  2026-05-15

  This thought-leadership article explores the mechanistic and strategic imperatives behind robust protein preservation in plant cell research, drawing on the latest findings in immune-metabolic regulation and advanced protease inhibition. It highlights the APExBIO Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) as a linchpin for translational workflows, integrating evidence from high-impact studies and best-in-class protocols. Readers will discover how integrating mechanistic insights—from energy metabolism’s role in immune signaling to targeted cysteine protease inhibition—can redefine experimental reproducibility and accelerate translational outcomes.

• PP 1 Src Family Tyrosine Kinase Inhibitor: Applied Workflows

  2026-05-14

  PP 1 stands out as a nanomolar-selective Src family tyrosine kinase inhibitor, enabling researchers to dissect oncogenic and immune signaling with exceptional precision. This article presents actionable workflow protocols, advanced use-cases in cancer and immunology, and troubleshooting strategies that maximize the value of PP 1 in translational research.

• OTUD3 Stabilizes SLC7A11 to Drive Sunitinib Resistance in cc

  2026-05-14

  This study uncovers how OTUD3 stabilizes the cystine transporter SLC7A11, conferring resistance to sunitinib in clear cell renal cell carcinoma (ccRCC) by suppressing ferroptosis. The findings reveal a novel resistance mechanism and suggest that targeting OTUD3 could restore therapeutic efficacy of sunitinib.

• Optimizing Cancer Models with RG7388: MDM2 Antagonist Protoc

  2026-05-13

  RG7388 empowers researchers to precisely activate the p53 pathway, enhance apoptosis in wild-type p53 cancer models, and drive robust tumor inhibition—especially when combined with chemoradiotherapy. This guide distills evidence-backed workflows and troubleshooting tips for maximizing experimental success with APExBIO’s selective MDM2 antagonist.

• FOXM1 Inhibition Enhances Venetoclax Sensitivity via ATP2B4

  2026-05-13

  This study demonstrates that combining the FOXM1 inhibitor RCM-1 with venetoclax (ABT-199) sensitizes rhabdomyosarcoma (RMS) cells to apoptosis by downregulating ATP2B4, a calcium transporter highly expressed in RMS. The findings reveal a mechanistic basis for overcoming solid tumor resistance to Bcl-2 inhibition and offer a rationale for new targeted therapy combinations.

• Naftifine HCl: Antifungal Mechanism and Research Benchmarks

  2026-05-12

  Naftifine HCl is a high-purity allylamine antifungal agent targeting squalene 2,3-epoxidase. Its robust activity underpins topical antifungal treatment models for tinea infections. This article details its mechanism, solubility, evidence, and optimal research use.

• Cy5 Goat Anti-Mouse IgG (H+L) Antibody: Precision Signal Amp

  2026-05-12

  Explore the advanced capabilities of the Cy5 Goat Anti-Mouse IgG (H+L) Antibody for high-sensitivity immunofluorescence, with a unique focus on protein particle vaccine workflows. Discover how this Cy5-conjugated secondary antibody optimizes signal amplification, storage, and detection in complex immunoassays.

• EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1

  2026-05-11

  EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent for in vitro peptide synthesis, bioconjugation, and nucleotide coupling. It enables efficient amide bond formation in aqueous workflows but is not intended for in vivo or clinical applications due to the absence of supporting data.

• Next-Gen Phosbind Acrylamide: Decoding Phosphorylation for T

  2026-05-11

  This thought-leadership article explores the transformative potential of Phos binding reagent (Phosbind) acrylamide for translational researchers investigating phosphorylation-driven cell signaling, metastasis, and kinase regulation. Drawing mechanistic insights from recent advances in metastatic cancer biology, we dissect how precise, antibody-free detection of phosphorylation events—using tools like Phosbind Acrylamide—can accelerate discovery, functional validation, and clinical translation. Comparative analysis, workflow guidance, and forward-looking perspectives are provided.

• Direct Mouse Genotyping Kit Plus: Fast, Reliable Mouse Genot

  2026-05-10

  The Direct Mouse Genotyping Kit Plus streamlines mouse genotyping by enabling rapid, purification-free DNA extraction and direct high-fidelity PCR, empowering researchers to validate gene knockouts and transgene presence with unmatched efficiency. Its integrated PCR master mix with dye reagents eliminates workflow bottlenecks, supporting robust colony management and complex genetic studies.

• PSPro Enables Single-Cell-Type Spatial Proteome Profiling in

  2026-05-09

  Mao et al. introduce PSPro, a proximity labeling-based workflow enabling simultaneous spatial proteome profiling of diverse cell types within intact tissue slices at single-cell-type resolution. Their method advances the field by optimizing antibody-targeted biotinylation and affinity purification, revealing spatial heterogeneity in the pancreatic tumor microenvironment.

• QNZ (EVP4593): Strategic NF-κB Modulation for Translational

  2026-05-09

  This article delivers deep mechanistic insights into QNZ (EVP4593) as a nanomolar NF-κB pathway inhibitor, paired with actionable guidance for translational researchers. Through critical analysis of recent findings—particularly the interplay between cytoskeletal regulation, viral pathobiology, and inflammation—researchers gain a roadmap for integrating QNZ into advanced neurodegenerative and inflammation models. The discussion bridges evidence from virology, anti-inflammatory research, and neurodegenerative disease, while highlighting best-practice workflows and APExBIO's validated product provenance.

• iPSC-Derived Organoids Enable Multilineage HEV Infection Mod

  2026-05-08

  This study establishes induced pluripotent stem cell (iPSC)-derived liver, intestinal, and brain organoids as robust platforms for modeling pangenotype hepatitis E virus (HEV) infection. The work advances understanding of HEV cellular tropism, pathogenesis, and offers a physiologically relevant alternative to traditional animal and cell-based systems.

452 records 18/31 page Previous Next First page 上5页 1617181920 下5页 Last page